2023–2024 COVID-19 vaccination coverage in pregnancy in ten healthcare delivery organizations in the United States
Data on COVID-19 vaccination coverage in pregnancy are sparse, with most literature focused on original monovalent and bivalent vaccines. We assessed coverage of 2023-2024 COVID-19 vaccines among pregnant women across ten health care organizations in the United States participating in the Vaccine Safety Datalink (VSD). Among 167,478 women aged 18-49 years with a pregnancy during September 2023-August 2024, 23,941 (14.3%) received a 2023-2024 COVID-19 vaccine dose prior to or during their pregnancy. We identified higher coverage with increasing age groups (range 4.8% to 21.2% vaccinated) and increasing healthcare utilization during pregnancy (range 9.8% to 17.6% vaccinated). We found differences in coverage by maternal race and ethnicity (range 7.2% to 23.2% vaccinated), and by calendar month of pregnancy start (range 1.3% to 17.6% vaccinated). Uptake of 2023-2024 COVID-19 vaccines was low in this population. The VSD will continue monitoring COVID-19 vaccination coverage in pregnancy in the 2024-2025 season, including coverage by maternal race and ethnicity.
Authors
- Allison L. Naleway (ORCID: https://orcid.org/0000-0001-5747-4643)
- Darios Getahun (ORCID: https://orcid.org/0000-0003-3610-8841)
- Matthew F. Daley (ORCID: https://orcid.org/0000-0003-1309-4096)
- Ousseny Zerbo (ORCID: https://orcid.org/0000-0002-8380-6215)
- Sungching Glenn (ORCID: https://orcid.org/0000-0002-0041-0996)
- Karen B. Jacobson (ORCID: https://orcid.org/0000-0003-3050-4595)
- Candace C. Fuller (ORCID: https://orcid.org/0000-0002-8902-1435)
- Teresa Schmidt (ORCID: https://orcid.org/0000-0003-2434-8223)
- Elyse O. Kharbanda (ORCID: https://orcid.org/0000-0003-1806-6502)
- Stephanie A. Irving (ORCID: https://orcid.org/0000-0001-7437-6797)
- Simon J. Hambidge (ORCID: https://orcid.org/0000-0002-7535-0668)
- Nancy S. Weinfield (ORCID: https://orcid.org/0000-0002-1417-2271)
- Bradley Crane (ORCID: https://orcid.org/0009-0006-5525-0324)
- Joshua T.B. Williams
- Sean T. O'Leary
- James G. Donahue
- Brian E. Dixon
- Lisa A. Jackson
- Katharine Raisler
Institutions
- Marshfield Clinic (US)
- Regenstrief Institute (US)
- Kaiser Permanente (US)
- Kaiser Permanente Washington Health Research Institute (US)
- Denver Health Medical Center (US)
- Harvard Pilgrim Health Care (US)
- Kaiser Permanente Center for Health Research (US)
- Ochin (US)
- Marshfield Clinic (US)
- HealthPartners (US)
- Indiana University – Purdue University Indianapolis (US)
- University of Colorado Denver (US)
Publication Details
- Journal
- Vaccine
- Published
- 2026-03-12
- DOI
- https://doi.org/10.1016/j.vaccine.2026.128441
- Primary Topic
- COVID-19 Impact on Reproduction
- Type
- article
- Field-Weighted Citation Impact
- 0.00